Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis

American Journal of Hematology

Volumn 85, Issue 5, 2010, Pages 380-383

  Sarmati, Loredana ^a   Beltrame, Angela ^a   Dori, Luca ^a   Maffongelli, Gaetano ^a   Cudillo, Laura ^a   De Angelis, Gottardo ^a   Picardi, Alessandra ^a   Ottaviani, Licia ^a   Cefalo, Maria Giovanna ^a   Venditti, Adriano ^a   Amadori, Sergio ^a   Arcese, William ^a   Andreoni, Massimo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; DIAGNOSTIC TEST; FEBRILE NEUTROPENIA; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; PRIORITY JOURNAL; THERAPY DELAY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CALCITONIN; FEMALE; FEVER; HUMANS; MALE; MIDDLE AGED; MUCOSITIS; NEUTROPENIA; PROTEIN PRECURSORS; ROC CURVE; SEPSIS; YOUNG ADULT;

EID: 77951610833     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21685     Document Type: Article

References (20)

1. Link H, Bohme A, Cornely OA, et al. Antimicrobial therapy of unexplained fever in neutropenic patients guidelines of the infectious diseases working party (AGIHO) of the German society of hematology and oncology (DGHO), study group interventional therapy of unexplained fever, arbeitsgemeinschaft supportivmassnahmen in der onkologie (ASO) of the Deutsche krebsgesellschaft (DKG-German cancer society). Ann Hematol 2003;82 (Suppl. 2):105-111.
2. Bodey GP, Buckley M, Sathe YS, et al. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-340.
3. Maruna P, Nedelnikova R, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res 2000;49:S57-S61.
4. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-518. (Pubitemid 23066085)
5. Simon P, Milbrandt EB, Emlet L. Procalcitonin-guided antibiotics in severe sepsis. Critical Care 2008;12:309.
6. Charles PE, Ladoire S, Snauwaert A, et al. Impact of previous sepsis on the accuracy of procalcitonin for the early diagnosis of blood stream infection in critically ill patients. BMC Infect Dis 2008;8:163.
7. Blijlevens NMA, Donnelly JP, Meis JFG, et al. Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation. Clin Diagn Lab Immunol 2000;7:889-892.
8. Schuttrumpf S, Binder L, Hagemann T, et al. Procalcitonin: A useful discriminator between febrile conditions of different origin in hemato-oncological patients? Ann Hematol 2003;82:98-103.
9. Sakr Y, Sponholz C, Tuche F, et al. The role of procalcitonin in febrile neutropenic patients: Review of the literature. Infection 2008;36:396-407.
10. Svaldi M, Hirber J, Lanthaler A, et al. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 2001;115:53-57. (Pubitemid 32995092)
11. Fleischhack G, Kambeck I, Cipic D, et al. Procalcitonin in paediatric cancer patients: Its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol 2000;111:1093-1102. (Pubitemid 32104921)
12. Svaldi M, Hirber J, Lanthaler AI, et al. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 2001;115:53-57. (Pubitemid 32995092)
13. Carnino L, Betteto S, Loiacono M, et al. Procalcitonin as a predictive marker of infections in chemoinduced neutropenia. J Cancer Res Clin Oncol, 2010; 136:611-615.
14. Semeraro M, Thomée C, Rolland E, et al. A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin. Pediatr Blood Cancer, 2010;54:284-290.
15. Hatzistilianou M, Rekliti A, Athanassiadou F, et al. Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia. Inflamm Res 2009, in press.
16. Martinez-Albarran M, Perez-Molina Jde J, Gallegos-Castorena S, et al. Procalcitonin and C-reactive protein serumlevels asmarkers of infection in a pediatric population with febrile neutropenia and cancer. Pediatr Hematol Oncol 2009;26:414-425.
17. Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteraemia caused by either gram negative or gram positive bacteria. BMC Infect Dis 2008;8:381-388
18. Kocazeybek B, Küçükoǧlu S, Öner YA. Procalcitonin and C-reactive protein in infective endocarditis: Correlation with etiology and prognosis. Chemotherapy 2003;49:76-84. (Pubitemid 36469802)
19. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, Bethesda, MD, USA. NIH, DHHS, March 31, 2003. Available at: http://ctep.cancer.gov, Publish on August 9, 2006.
20. Przepiorka D, Weisdorf D, Martin P, et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995;15:825-828.